171 related articles for article (PubMed ID: 28099404)
1. Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 Cases.
Ducroux E; Martin C; Bouwes Bavinck JN; Decullier E; Brocard A; Westhuis-van Elsäcker ME; Lebbé C; Francès C; Morelon E; Legendre C; Joly P; Kanitakis J; Jullien D; Euvrard S; Dantal J
Transplantation; 2017 Apr; 101(4):e133-e141. PubMed ID: 28099404
[TBL] [Abstract][Full Text] [Related]
2. Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.
Rizvi SMH; Aagnes B; Holdaas H; Gude E; Boberg KM; Bjørtuft Ø; Helsing P; Leivestad T; Møller B; Gjersvik P
JAMA Dermatol; 2017 Dec; 153(12):1270-1277. PubMed ID: 29049612
[TBL] [Abstract][Full Text] [Related]
3. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
4. Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus.
Hoogendijk-van den Akker JM; Harden PN; Hoitsma AJ; Proby CM; Wolterbeek R; Bouwes Bavinck JN; de Fijter JW
J Clin Oncol; 2013 Apr; 31(10):1317-23. PubMed ID: 23358973
[TBL] [Abstract][Full Text] [Related]
5. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.
Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Geiran O; Fauchald P; Simonsen S
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):177-86. PubMed ID: 10025742
[TBL] [Abstract][Full Text] [Related]
6. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma.
Moloney FJ; Kelly PO; Kay EW; Conlon P; Murphy GM
Dermatol Surg; 2004 Apr; 30(4 Pt 2):674-8. PubMed ID: 15061854
[TBL] [Abstract][Full Text] [Related]
7. A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.
Caillard S; Cellot E; Dantal J; Thaunat O; Provot F; Janbon B; Buchler M; Anglicheau D; Merville P; Lang P; Frimat L; Colosio C; Alamartine E; Kamar N; Heng AE; Durrbach A; Moal V; Rivalan J; Etienne I; Peraldi MN; Moreau A; Moulin B;
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1663-1670. PubMed ID: 28818847
[TBL] [Abstract][Full Text] [Related]
8. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
[TBL] [Abstract][Full Text] [Related]
9. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center.
Ferreira FR; Ogawa MM; Nascimento LF; Tomimori J
An Bras Dermatol; 2014; 89(5):745-50. PubMed ID: 25184913
[TBL] [Abstract][Full Text] [Related]
11. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma.
Euvrard S; Kanitakis J; Decullier E; Butnaru AC; Lefrançois N; Boissonnat P; Sebbag L; Garnier JL; Pouteil-Noble C; Cahen R; Morelon E; Touraine JL; Claudy A; Chapuis F
Transplantation; 2006 Apr; 81(8):1093-100. PubMed ID: 16641592
[TBL] [Abstract][Full Text] [Related]
12. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
13. Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients.
Shao EX; Betz-Stablein B; Marquat L; Campbell S; Isbel N; Green AC; Plasmeijer EI
Transpl Immunol; 2022 Dec; 75():101698. PubMed ID: 35988897
[TBL] [Abstract][Full Text] [Related]
14. Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.
Lanz J; Bouwes Bavinck JN; Westhuis M; Quint KD; Harwood CA; Nasir S; Van-de-Velde V; Proby CM; Ferrándiz C; Genders RE; Del Marmol V; Forchetti G; Hafner J; Vital DG; Hofbauer GFL
JAMA Dermatol; 2019 Jan; 155(1):66-71. PubMed ID: 30516812
[TBL] [Abstract][Full Text] [Related]
15. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
17. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
18. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
Krynitz B; Edgren G; Lindelöf B; Baecklund E; Brattström C; Wilczek H; Smedby KE
Int J Cancer; 2013 Mar; 132(6):1429-38. PubMed ID: 22886725
[TBL] [Abstract][Full Text] [Related]
19. Skin tumours in the West of Scotland renal transplant population.
Mackintosh LJ; Geddes CC; Herd RM
Br J Dermatol; 2013 May; 168(5):1047-53. PubMed ID: 23137036
[TBL] [Abstract][Full Text] [Related]
20. Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients.
Crespo E; Fernandez L; Lúcia M; Melilli E; Lauzurica R; Penin RM; Quer A; Luque S; Quero M; Manonelles A; Torras J; Cruzado JM; Cañas L; Grinyó JM; Bestard O
Transplantation; 2017 Sep; 101(9):2102-2110. PubMed ID: 28403126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]